Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 9 reviews

533%
433%
333%
20%
10%
Ask AI

Ask AI about Evol science

Generated with AI from 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Evol science

Evol Science is a startup biotechnology company focused on identifying and therapeutically exploiting mechanisms of cancer cell resistance, which they discover using their proteo-genomic system and proprietary AI-driven data analytic platform.

Evol's platform identifies and targets cancer cell drug resistance, acquired and intrinsic, accelerating and de-risking drug development and clinical translation. They generate a novel pipeline for our BioPharma partners and license out our IP, expanding their patient reach. Evol’s first biological discovery has generated multiple novel drug combinations to treat late-stage, RAS-driven cancers including metastatic melanoma, pancreatic, colorectal, breast, and lung. They expect to have their first combination in proof-of-principle clinical trials in the first half of 2019. Their goal is to make the deadliest cancers survivable.

Categories
Biotechnology